Try our beta test site
1 study found for:    Lymphoma OR CLL | ASN002
Show Display Options
Rank Status Study
1 Recruiting A Phase 1/2, Dose Escalation, Cohort Expansion Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Preliminary Efficacy Of ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors
Conditions: Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Mantle-Cell;   Lymphoma, Follicular;   Cancer;   Neoplasm;   Tumor;   Lymphoma, Malignant;   Lymphoma, B-cell;   Lymphoma, Non-Hodgkin
Interventions: Drug: ASN002 Dose Escalation;   Drug: ASN002 MTD

Study has passed its completion date and status has not been verified in more than two years.